Pediatric Vaccine Market Analysis 2025–2029: Growth Forecast and Competitive Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the pediatric vaccine market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Pediatric Vaccine Market Be Worth By 2029, And What CAGR Will It Achieve?

The pharmacogenetic testing market has experienced significant expansion in its size during recent years. It is forecast to rise from $12.37 billion in 2024 to $14.33 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 15.8%. This growth observed in the past can be ascribed to an increase in overall drug efficacy, the expanding acceptance of personalized medicine, a rising requirement for precise diagnoses, an enhanced focus on pharmacogenetic testing, and escalating medical expenses.

The pharmacogenetic testing market is anticipated to experience substantial growth over the next few years. It is projected to expand to $25.62 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 15.6%. The expansion during the forecast period is driven by increased research and development within biotechnology and healthcare, rising healthcare expenditure, a growing prevalence of chronic diseases, enhanced accessibility, and the emergence of telemedicine and digital health. Dominant trends expected in this period include developments in pharmacogenetic testing, progress in genomic technologies, general technological advancements, improvements in companion diagnostics, and the introduction of innovative diagnostic tests.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp

Which Factors Are Driving The Pediatric Vaccine Market Forward?

The growing need for personalized medicine is projected to drive expansion within the pharmacogenetic testing market going forward. Also known as precision medicine, personalized medicine represents a medical strategy where healthcare choices and treatments are customized to each patient’s unique attributes. The rise of personalized medicine stems from multiple factors, including enhanced treatment results, an emphasis on disease prevention and prompt diagnosis, and its economic efficiency. Pharmacogenetic testing plays a crucial role in personalized medicine, as it examines a person’s genetic composition to forecast their reaction to particular drugs. This allows healthcare professionals to customize treatments according to genetic factors, thereby maximizing drug effectiveness and reducing unwanted side effects. For example, data from the Personalized Medicine Coalition, a US-based non-profit organization, indicated that in February 2024, the FDA gave approval to 16 new personalized therapies for rare disease patients in 2023, a significant increase from six in 2022. Consequently, the escalating demand for personalized medicine is a key driver for the expansion of the pharmacogenetic testing market.

Which Segments Form The Key Structure Of The Pediatric Vaccine Market?

The pharmacogenetic testing market covered in this report is segmented –

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

What Strategic Shifts And Innovations Are Influencing The Pediatric Vaccine Market?

Major companies within the pharmacogenetics testing market are developing sophisticated pharmacogenomics testing services, including prescription-based pharmacogenetic testing, to secure a competitive edge. Prescription-based pharmacogenetic testing refers to genetic assessments specifically ordered or prescribed by healthcare providers to analyze a patient’s genetic makeup prior to medication prescription. For instance, in May 2023, UCSF, a US-based healthcare company, introduced its pharmacogenomics testing service. This service is designed to enhance the precision of medical treatments. UCSF’s pharmacogenomics testing service assists healthcare providers in tailoring drug therapies based on an individual’s genetic profile, with the aim of boosting drug efficacy, reducing adverse reactions, and supporting personalized medicine strategies.

Which Firms Are Making The Biggest Impact In The Pediatric Vaccine Market?

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

Which Region Is Expected To Lead The Pediatric Vaccine Market In The Next Few Years?

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=19139&type=smp

Browse Through More Reports Similar to the Global Pediatric Vaccine Market 2025, By The Business Research Company

Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Epigenetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Optogenetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795